Cancer during pregnancy: An analysis of 215 patients emphasizing the obstetrical and the Neonatal outcomes

Journal of Clinical Oncology

Volumn 28, Issue 4, 2010, Pages 683-689

  Van Calsteren, Kristel ^a   Heyns, Liesbeth ^a   De Smet, Frank ^a   Van Eycken, Liesbet ^a   Gziri, Mina Mhallem ^a   Van Gemert, Willemijn ^a   Halaska, Michael ^a   Vergote, Ignace ^a   Ottevanger, Nelleke ^a   Amant, Frédéric ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOTOXIC AGENT; DAUNORUBICIN; DOXORUBICIN; FLUOROURACIL; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; MONOCLONAL ANTIBODY; PREDNISONE; PROCARBAZINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERFERON; VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; BIRTH WEIGHT; BREAST CANCER; CANCER DIAGNOSIS; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURGERY; CHILD; CLINICAL ASSESSMENT; CONGENITAL MALFORMATION; CONTROLLED STUDY; CRYOTHERAPY; DELIVERY; FEMALE; FETUS OUTCOME; GESTATIONAL AGE; GYNECOLOGIC CANCER; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; LEUKOPENIA; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIMODALITY CANCER THERAPY; NEWBORN; NEWBORN INTENSIVE CARE; OVARY CANCER; PANCYTOPENIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PREMATURE LABOR; PREMATURITY; PREVALENCE; PRIORITY JOURNAL; SKIN CANCER; SMALL FOR DATE INFANT; SPONTANEOUS ABORTION; CLINICAL TRIAL; INTERNATIONAL COOPERATION; MULTICENTER STUDY; PROGNOSIS; RISK ASSESSMENT; STATISTICS; TUMOR RECURRENCE;

ADULT; BIRTH WEIGHT; DELIVERY, OBSTETRIC; FEMALE; GESTATIONAL AGE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INTENSIVE CARE, NEONATAL; INTERNATIONAL AGENCIES; NEOPLASM RECURRENCE, LOCAL; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; PROGNOSIS; RISK ASSESSMENT;

EID: 77449146415     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.23.2801     Document Type: Article

References (34)

1. Ní Mhuireachtaigh R, O'Gorman DA: Anesthesia in pregnant patients for nonobstetric surgery. J Clin Anesth 18:60-66, 2006 (Pubitemid 43330772)
2. Moran BJ, Yano H, Al Zahir N, et al: Conflicting priorities in surgical intervention for cancer in pregnancy. Lancet Oncol 8:536-544, 2007 (Pubitemid 46805911)
3. Briggs GG, Freeman RK, Yaffe SJ: Drugs in Pregnancy and Lactation. Philadelphia, PA, Lippincott Williams & Wilkins, 2008
4. Cardonick E, Iacobucci A: Use of chemotherapy during human pregnancy. Lancet Oncol 5:283-291, 2004
5. Kal HB, Struikmans H: Radiotherapy during pregnancy: Fact and fiction. Lancet Oncol 6:328-333, 2005
6. Ring AE, Smith IE, Jones A, et al: Chemotherapy for breast cancer during pregnancy: An 18-year experience from five London teaching hospitals. J Clin Oncol 23:4192-4197, 2005 (Pubitemid 46211325)
7. Mir O, Berveiller P, Ropert S, et al: Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Ann Oncol 19:607-613, 2008 (Pubitemid 351461028)
8. Avilés A, Neri N: Hematological malignancies and pregnancy: A final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2:173-177, 2001 (Pubitemid 34092723)
9. Hahn KM, Johnson PH, Gordon N, et al: Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 107:1219-1226, 2006
10. Pavlidis NA: Coexistence of pregnancy and malignancy. Oncologist 7:279-287, 2002
11. Stensheim H, Moller B, van Dijk T, et al: Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: A registry-based cohort study. J Clin Oncol 27:45-51, 2009
12. Belgian Cancer Registry: Yearly statistics. http://www.kankerregister. org/
13. Pereg D, Koren G, Lishner M: Cancer in pregnancy: Gaps, challenges and solutions. Cancer Treat Rev 34:302-312, 2008
14. Goldenberg RL, Culhane JF, Iams JD, et al: Epidemiology and causes of preterm birth. Lancet 371:75-84, 2008
15. Queisser-Luft A, Stolz G, Wiesel A, et al: Malformations in newborn: Results based on 30,940 infants and fetuses from the Mainz congenital birth defect monitoring system (1990-1998). Arch Gynecol Obstet 266:163-167, 2002
16. Drew JH, Parkinson P, Walstab JE, et al: Incidences and types of malformations in newborn infants. Med J Aust 1:945-949, 1977
17. Merks JH, van Karnebeek CD, Caron HN, et al: Phenotypic abnormalities: Terminology and classification. Am J Med Genet A 123A:211-230, 2003
18. Bastek JA, Sammel MD, Pare E, et al: Adverse neonatal outcomes: Examining the risks between preterm, late preterm, and term infants. Am J Obstet Gynecol 199:367-368, 2008
19. Johnson S: Cognitive and behavioural outcomes following very preterm birth. Semin Fetal Neonatal Med 12:363-373, 2007
20. Cold S, During M, Ewertz M, et al: Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG). Br J Cancer 93:627-632, 2005
21. Nettleton J, Long J, Kuban D, et al: Breast cancer during pregnancy: Quantifying the risk of treatment delay. Obstet Gynecol 87:414-418, 1996 (Pubitemid 26075081)
22. Duggan B, Muderspach LI, Roman LD, et al: Cervical cancer in pregnancy: Reporting on planned delay in therapy. Obstet Gynecol 82:598-602, 1993 (Pubitemid 23278265)
23. Larsen WJ: Human Embryology. Philadelphia, PA, Churchill Livingstone, 2001
24. Fischer D, Ahr A, Schaefer B, et al: Outcome of preterm and term neonates of mothers with malignant diseases diagnosed during pregnancy. J Matern Fetal Neonatal Med 19:101-103, 2006
25. Weisz B, Schiff E, Lishner M: Cancer in pregnancy: Maternal and fetal implications. Hum Reprod Update 7:384-393, 2001 (Pubitemid 32655324)
26. Nulman I, Laslo D, Fried S, et al: Neurodevelopment of children exposed in utero to treatment of maternal malignancy. Br J Cancer 85:1611-1618, 2001 (Pubitemid 34081501)
27. Wadhwa PD, Sandman CA, Porto M, et al: The association between prenatal stress and infant birth weight and gestational age at birth: A prospective investigation. Am J Obstet Gynecol 169:858-865, 1993
28. Dole N, Savitz DA, Hertz-Picciotto I, et al: Maternal stress and preterm birth. Am J Epidemiol 157:14-24, 2003
29. Glynn LM, Schetter CD, Hobel CJ, et al: Pattern of perceived stress and anxiety in pregnancy predicts preterm birth. Health Psychol 27:43-51, 2008
30. Arias F, Rodriquez L, Rayne SC, et al: Maternal placental vasculopathy and infection: Two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 168:585-591, 1993 (Pubitemid 23069118)
31. Lei H, Furth EE, Kalluri R, et al: A program of cell death and extracellular matrix degradation is activated in the amnion before the onset of labor. J Clin Invest 98:1971-1978, 1996
32. McLaren J, Taylor DJ, Bell SC: Increased incidence of apoptosis in non-labour-affected cytotrophoblast cells in term fetal membranes overlying the cervix. Hum Reprod 14:2895-2900, 1999 (Pubitemid 29520715)
33. Henau K, Renard F, De Gendt C: Cancer Incidence in Belgium 2004-2005. Belgian Cancer Registry D/2008/11.846/1, Brussels, 2008
34. Smith LH, Danielsen B, Allen ME, et al: Cancer associated with obstetric delivery: Results of linkage with the California Cancer Registry. Am J Obstet Gynecol 189:1128-1135, 2003 (Pubitemid 37373909)